Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Cook

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Medrxiv : the Preprint Server for Health Sciences|May 22, 2023
Tracking the prevalence and emergence of SARS CoV2 variants of concern using a regional genomic surveillance programAna Jung, Lindsay Droit, Binita Febles, et al.
Neurology|February 20, 2025
Real-world Evidence of Adding Atogepant to OnabotulinumtoxinA for Control of Chronic Migraine: A Retrospective Chart Review (P4-12.001)Andrew Blumenfeld, Laszlo Mechtler, Lisa Cook, et al.
International Journal of Integrated Care|May 31, 2022
Integrating Care from Home to Hospital to Home: Using Participatory Design to Develop a Provincial Transitions in Care GuidelineRobin L Walker, Staci Hastings, Charles Cook, et al.
Pain and Therapy|September 17, 2024
Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart ReviewAndrew M Blumenfeld, Laszlo Mechtler, Lisa Cook, et al.
Infectious Diseases and Therapy|September 20, 2020
Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical TrialDanyal Ibrahim, Latha Dulipsingh, Lisa Zapatka, et al.
Journal of Hand Therapy : Official Journal of the American Society of Hand Therapists|March 13, 2023
Adult norms for the Corbett Targeted Coin TestJeanine Beasley, Lisa Cook, Carleigh Eidson, et al.
Neuromuscular Disorders : NMD|October 24, 2015
Divalent cation-responsive myotonia and muscle paralysis in skeletal muscle sodium channelopathyAmi Mankodi, Christopher Grunseich, Martin Skov, et al.
Haematologica|November 16, 2016
Effect of high-dose plerixafor on CD34<sup>+</sup> cell mobilization in healthy stem cell donors: results of a randomized crossover trialJeremy Pantin, Enkhtsetseg Purev, Xin Tian, et al.
Cytotherapy|May 17, 2014
The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventative treatment approachesNatasha A Jain, Kit Lu, Sawa Ito, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2014
Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuriaJeremy Pantin, Xin Tian, Nancy Geller, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Medrxiv : the Preprint Server for Health Sciences|May 22, 2023
Tracking the prevalence and emergence of SARS CoV2 variants of concern using a regional genomic surveillance programAna Jung, Lindsay Droit, Binita Febles, et al.
Neurology|February 20, 2025
Real-world Evidence of Adding Atogepant to OnabotulinumtoxinA for Control of Chronic Migraine: A Retrospective Chart Review (P4-12.001)Andrew Blumenfeld, Laszlo Mechtler, Lisa Cook, et al.
International Journal of Integrated Care|May 31, 2022
Integrating Care from Home to Hospital to Home: Using Participatory Design to Develop a Provincial Transitions in Care GuidelineRobin L Walker, Staci Hastings, Charles Cook, et al.
Pain and Therapy|September 17, 2024
Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart ReviewAndrew M Blumenfeld, Laszlo Mechtler, Lisa Cook, et al.
Infectious Diseases and Therapy|September 20, 2020
Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical TrialDanyal Ibrahim, Latha Dulipsingh, Lisa Zapatka, et al.
Journal of Hand Therapy : Official Journal of the American Society of Hand Therapists|March 13, 2023
Adult norms for the Corbett Targeted Coin TestJeanine Beasley, Lisa Cook, Carleigh Eidson, et al.
Neuromuscular Disorders : NMD|October 24, 2015
Divalent cation-responsive myotonia and muscle paralysis in skeletal muscle sodium channelopathyAmi Mankodi, Christopher Grunseich, Martin Skov, et al.
Haematologica|November 16, 2016
Effect of high-dose plerixafor on CD34<sup>+</sup> cell mobilization in healthy stem cell donors: results of a randomized crossover trialJeremy Pantin, Enkhtsetseg Purev, Xin Tian, et al.
Cytotherapy|May 17, 2014
The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventative treatment approachesNatasha A Jain, Kit Lu, Sawa Ito, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2014
Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuriaJeremy Pantin, Xin Tian, Nancy Geller, et al.
Pageof 4